Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB00537_nanopub.RAOWVibmApcc_c7wRAlCXefnnlJvr7F1aS6-hMsobbwC0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB00537 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB00537 label "DDI between Tacrine and Ciprofloxacin - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Ciprofloxacin. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Ciprofloxacin is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00382_DB00537]" assertion.
- drugbank_resource:DB00382_DB00537 identifier "drugbank_resource:DB00382_DB00537" assertion.
- drugbank_resource:DB00382_DB00537 title "DDI between Tacrine and Ciprofloxacin - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Ciprofloxacin. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Ciprofloxacin is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00537 assertion.
- drugbank:DB00537 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00537 assertion.